US2012165400A1PendingUtilityA1
Gene repair involving in vivo excision of targeting dna
Est. expiryFeb 3, 2019(expired)· nominal 20-yr term from priority
C12N 15/902C12N 2799/021A61K 48/00A61P 43/00
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods of modifying, repairing, attenuating and inactivating a gene or other chromosomal DNA in a cell are disclosed. Also disclosed are methods of treating or prophylaxis of a genetic disease in an individual in need thereof.
Claims
exact text as granted — not AI-modified1 . A method of treating or prophylaxis of a genetic disease in an individual in need thereof comprising the steps of:
a) introducing into the individual cells which comprise a first vector comprising targeting DNA, wherein said targeting DNA is flanked by a restriction endonuclease site and comprises (1) DNA homologous to chromosomal DNA adjacent to a specific sequence of interest and (2) DNA which repairs the specific sequence of interest upon recombination between said targeting DNA and the chromosomal DNA; and b) introducing into the individual a second vector comprising a nucleic acid encoding a restriction endonuclease which cleaves the restriction endonuclease site present in the first vector.
2 . The method of claim 1 wherein the first vector is a viral vector.
3 . The method of claim 2 wherein the second vector is a viral vector.
4 . The method of claim 2 wherein the first vector is a plasmid.
5 . The method of claim 1 wherein said targeting DNA is flanked by two restriction endonuclease sites.
6 . A method for treating or prophylaxis of a genetic disease in an individual in need thereof comprising the steps of:
a) introducing into the individual cells which comprise a vector comprising targeting DNA, wherein said targeting DNA is flanked by a restriction endonuclease site and comprises (1) DNA homologous to chromosomal DNA adjacent to a specific sequence of interest and (2) DNA which repairs the specific sequence of interest upon recombination between said targeting DNA and the chromosomal DNA; and b) introducing into the cell a restriction endonuclease which cleaves the restriction endonuclease site present in the vector.
7 . The method of claim 6 wherein the vector is a viral vector.
8 . The method of claim 6 wherein said targeting DNA is flanked by two restriction endonuclease sites.Join the waitlist — get patent alerts
Track US2012165400A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.